U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06939556) titled 'High-throughput Serological Testing of Antibodies Platform for Adult Cohorts' on March 25.
Brief Summary: In the case of large emergency serosurveys, innovation in the sampling techniques is an often neglected, but relevant aspect to facilitate the enrolment of subjects in both adult and paediatric populations. Further, neutralization assays are the first line of response immediately after the emergence of a novel virus in the human population. This study aims at developing at IZSVe 384-format high-throughput neutralization assays for emerging and re-emerging respiratory viruses with pandemic potential to increase the preparedness ...